• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lindgren builds for global growth

Article

Lindgren RF Enclosures purchased the assets of a second Californiashielding company this month. The acquisition further strengthensthe firm's position on the West Coast. While Lindgren's MRI shielding business is secondary to itscommercial and

Lindgren RF Enclosures purchased the assets of a second Californiashielding company this month. The acquisition further strengthensthe firm's position on the West Coast.

While Lindgren's MRI shielding business is secondary to itscommercial and government work, the new businesses will strengthenLindgren's overall product portfolio and help the firm expandoverseas, said president William Curran.

Lindgren, based in Glendale Heights, IL, purchased the assetsof ShieldCo International of Ontario, CA, in July (SCAN 9/11/91).This business will be combined with that of LectroMagnetics (LMI)to form Lindgren's LectroMagnetics (West Coast) division. Thedivision will be based at the LectroMagnetics facility in LosAngeles, Curran said.

LectroMagnetics was the leading supplier of welded rooms usedin industrial and government shielding applications, he said.

"We looked at the LMI acquisition as an opportunity toexpand our domestic market presence in the industrial and governmentarea. It also provides us with a broader portfolio of productsto offer in the international market, which is becoming far moreactive," Curran told SCAN.

MRI radio-frequency and magnetic shielding remains Lindgren'slargest business, but the anticipated growth of new MRI installationsin the U.S. is expected to drop off. International MRI installations,however, should proliferate.

"We experienced phenomenal growth as a result of MR: 40%plus a year," Curran said. "That is going to slow down.Input from (scanner) manufacturers indicates that the (U.S.) growthrate is tapering off. Overseas, that is not the case," hesaid.

Lindgren is already active in Central and South America, theMiddle East and Asia/Pacific. It is present in Europe througha licensee, he said.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.